Powered by

Radient Technologies Inc. Announces Approval and Receipt of Controlled Drugs and Substances Licence from Health Canada

Feb 06, 2018 - News Bites Canadian Markets

CANADIAN DAILY STOCK REPORT

Corporate Wire Date: 05 February 2018 15:26 EST

ORIGINAL ANNOUNCEMENT [Text]

EDMONTON, Alberta, Feb. 05, 2018 -- Radient Technologies Inc. ("Radient" or the "Company") (TSX-V:RTI) is pleased to announce that its application for the Controlled Drugs and Substances Licence has been approved by Health Canada.

Pursuant to provisions of the Controlled Drugs and Substances Act and its Regulations, receipt of the Controlled Drugs and Substances Licenc...